CONNECT WITH US
HealthTech

HealthTech

Backed by Amish and Mennonites, a new kind of gene therapy company takes shape

Endpoints News logo

Published on

Add as a preferred source on Google
Backed by Amish and Mennonites, a new kind of gene therapy company takes shape

Hannah Dolins (left) and Lorraine Martin with the cow Royal Lite. (Credit: Karen Dolins)

Backed by Amish and Men­non­ites, a new kind of gene ther­a­py com­pa­ny takes shape

LAN­CAST­ER, PA — This spring, Lor­raine and Mark Mar­tin, a Men­non­ite fam­i­ly with a tax busi­ness, adopt­ed a stub­by-legged cow named Roy­al Lite.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Den­mark's Gubra looks be­yond me­tab­o­lism, hopes for first port­fo­lio com­pa­ny this year October 27, 2026

Be­yond the can­cer vac­cine, how did Mer­ck’s on­col­o­gy pipeline do at ES­MO? October 26, 2026

EGFR-mu­tant lung can­cer is an ADC bat­tle­ground, with Chi­na lead­ing the charge October 26, 2026

Trea­sury's COINS rule draft would nar­row the path for Chi­na biotech deal­mak­ing, ex­perts say

Arti­va to wind down af­ter two pa­tient deaths in au­toim­mune cell ther­a­py tri­als

Post-Makary FDA wins over in­vestors, but not sci­en­tists or Big Phar­ma: Sig­nal Sur­vey



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.